This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jul;54(7):1349-50.

doi: 10.3109/10428194.2012.753451. Epub 2012 Dec 24.

Extramedullary multiple myeloma: extraosseous relapse is extra "bad news," but why?

Philippe Moreau¹, Aaron Polliack

Affiliations

PMID: 23190391
DOI: 10.3109/10428194.2012.753451

Comment

Extramedullary multiple myeloma: extraosseous relapse is extra "bad news," but why?

Philippe Moreau et al. Leuk Lymphoma. 2013 Jul.

. 2013 Jul;54(7):1349-50.

doi: 10.3109/10428194.2012.753451. Epub 2012 Dec 24.

Authors

Philippe Moreau¹, Aaron Polliack

Affiliation

¹ University of Nantes, Nantes, France. philippe.moreau@chu-nantes.fr

PMID: 23190391
DOI: 10.3109/10428194.2012.753451

No abstract available

PubMed Disclaimer

Comment on

Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse.
Papanikolaou X, Repousis P, Tzenou T, Maltezas D, Kotsopoulou M, Megalakaki K, Angelopoulou M, Dimitrakoloulou E, Koulieris E, Bartzis V, Pangalis G, Panayotidis P, Kyrtsonis MC. Papanikolaou X, et al. Leuk Lymphoma. 2013 Jul;54(7):1459-64. doi: 10.3109/10428194.2012.746683. Epub 2012 Dec 14. Leuk Lymphoma. 2013. PMID: 23151071

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program